NCT01678001View on ClinicalTrials.gov

Treatment of Plantar Fasciitis With Xeomin

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Plantar Fascitis
Interventions
DRUG

Xeomin

Group A will consist of 25 patients that receive Xeomin. Group B will contain the other 25 patients that receive the placebo saline solution. Post-injection treatment will be kept the same between the two groups. This will only consist of plantar fascial stretching done 3 times daily.

Trial Locations (1)

19107

Rothman Institute Orthopaedics, Philadelphia

All Listed Sponsors
collaborator

Merz North America, Inc.

INDUSTRY

lead

Rothman Institute Orthopaedics

OTHER

NCT01678001 - Treatment of Plantar Fasciitis With Xeomin | Biotech Hunter | Biotech Hunter